Naltrexone, Bupropion

Mysimba 8 MG/90 MG Comprimidos de Liberacion Prolongada

8 mg + 90 mg comprimido de liberación prolongadaSpainAuthorisedAuthorised 10 Oct 2016

In other countries

The same active substances on other registers, the same brand first.

MysimbaEuropean Union · Orexigen Therapeutics Ireland LimitedSame brand
MysimbaCroatiaSame brand
MysimbaItaly · Compressa a rilascio prolungato · Orexigen Therapeutics Ireland LimitedSame brand
Mysimba 8 mg/90 mg tabletten met verlengde afgifteNetherlands · Tablet met verlengde afgifte · Orexigen Therapeutics Ireland LimitedSame brand
MYSIMBA 8 mg/90 mgRomania · 8mg/90mg · compr. elib. prel. · Orexigen Therapeutics Ireland LimitedSame brand
Mysimba®Serbia · 90mg+8mg · tableta sa produženim oslobađanjem · Pharmaswiss D.O.O., BeogradSame brand
ContraveCanada · 90 MG + 8 MG · Tablet (Extended-Release) · Bausch Health, Canada INC.Same form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Naltrexone, Bupropion

Mysimba 8 MG/90 MG Comprimidos de Liberacion Prolongada

8 mg + 90 mg comprimido de liberación prolongadaSpainAuthorisedAuthorised 10 Oct 2016

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Contrave Prolonged Release Tablet 8MG/90MGSingapore · 90mg + 8.00mg · tablet, film coated, extended release · Inova Pharmaceuticals (Singapore) Pte. Limited

ContraveUnited States · 90MG; 8MG · tablet, extended release · Nalpropion

Naltrexone Hydrochloride; Bupropion HydrochlorideUnited States · 8MG/90MG · tablet, extended release · Actavis Labs FL INC

BupnalBrazil · Supera Farma Laboratórios S.A

cloridrato de bupropiona + cloridrato de naltrexonaBrazil · Eurofarma Laboratorios S.A.

ContraveBrazil · Merck S/A

ContraveSaudi Arabia · Patheon INC

Packs

Pack	Code	Status
MYSIMBA 8 MG/90 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 112 comprimidos	712882

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Naltrexone, Bupropion
Strength: 8 mg + 90 mg
Dosage form: comprimido de liberación prolongada
Route: vía oral
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 10 Oct 2016
Registration: 114988001
Marketing authorisation holder: Orexigen Therapeutics Ireland Limited
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica